BRIEF

on Catheter Precision, Inc

Catheter Precision to Attend International VT Symposium in NYC

Catheter Precision, Inc. announced its participation in the 19th International Ventricular Tachycardia (VT) Symposium in New York City on October 11-12, 2024. The event is hosted by the University of Pennsylvania and Mount Sinai Hospital, focusing on ventricular arrhythmia management, including non-drug therapies.

David Jenkins, CEO of Catheter Precision, highlighted the importance of the symposium, mentioning that it offers a platform to engage with physicians treating ventricular arrhythmias. The company's VIVO™ system aids in pre-procedure identification of arrhythmia origins, enhancing procedure efficiency.

VIVO™ is a non-invasive 3D imaging system with FDA clearance and CE mark, designed to optimize ventricular ablation planning and reduce patient risks.

R. E.

Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all Catheter Precision, Inc news